2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine

2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine Suppliers list
Company Name: Pure Chemistry Scientific Inc.  
Tel: 001-857-928-2050 or 1-888-588-9418
Email: sales@chemreagents.com
Company Name: Shanghai Hanhong Scientific Co.,Ltd.  
Tel: 021-54306202 13764082696
Email: info@hanhongsci.com
Company Name: Nanjing JinruiJiuAn Biotechnology Co., Ltd.  
Tel: 025-58196018 800028039
Email: sales@fartop.net
Company Name: Haoyuan Chemexpress Co., Ltd.  
Tel: 021-58950125
Email: info@chemexpress.com
Company Name: 9ding chemical ( Shanghai) Limited  
Tel: 4009209199
Email: sales@9dingchem.com
2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine Basic information
Product Name:2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine
Synonyms:2,4-Dichloro-7-(toluene-4-sulfonyl)-7H-pyrrolo[2,3-d]pyriMidine;7H-Pyrrolo[2,3-d]pyriMidine, 2,4-dichloro-7-[(4-Methylphenyl)sulfonyl]-;2,4-Dichloro-7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidine;2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine;2,4-Dichloro-7-(p-tolylsulfonyl)pyrrolo[2,3-d]pyrimidine;,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine;2,4-dichloro-7-(4-methylbenzenesulfonyl)-7H-pyrrolo[2,3-d]pyrimidine;2,4-dichloro-7-(4-methylphenyl)sulfonylpyrrolo[2,3-d]pyrimidine
CAS:934524-10-4
MF:C13H9Cl2N3O2S
MW:342.2
EINECS:
Product Categories:Heterocycle-Pyrimidine series
Mol File:934524-10-4.mol
2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine Structure
2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine Chemical Properties
Melting point 163-164°
Boiling point 447.1±55.0 °C(Predicted)
density 1.59
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
pka0.47±0.30(Predicted)
AppearanceOff-white to light yellow Solid
Safety Information
MSDS Information
2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine Usage And Synthesis
Synthesis
2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE

90213-66-4

Tosyl chloride

98-59-9

2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine

934524-10-4

Using 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine (1.00 g, 5.32 mmol) and p-toluenesulfonyl chloride (1.115 g, 5.85 mmol) as the raw materials, the two were dissolved in dichloromethane (20 mL) along with tetrabutylammonium hydrogen sulfate (0.090 g, 0.27 mmol) at room temperature. Subsequently, 50% aqueous sodium hydroxide solution (1 mL) was added to the reaction mixture and stirred at room temperature for 30 min. The progress of the reaction was monitored by thin layer chromatography (TLC) and after confirming the completion of the reaction, the reaction mixture was diluted with deionized water and dichloromethane and the organic layer was separated. The organic layer was concentrated by vacuum evaporation to give a light yellow solid. The crude product was purified by column chromatography (100% dichloromethane as eluent) to afford the target product 2,4-dichloro-7-toluenesulfonyl-7H-pyrrolo[2,3-d]pyrimidine (1.76 g, 97% yield) as a white solid. The mass spectrum (LCMS) showed [M + H]+ m/z 342. 1H NMR (400 MHz, chloroform-d) δ ppm: 8.14 (d, J = 8.59 Hz, 2H), 7.78 (d, J = 3.79 Hz, 1H), 7.39 (d, J = 8.59 Hz, 2H), 6.70 (d, J = 3.79 Hz, 1H). 2.45 (s, 3H).

References[1] Patent: WO2010/38060, 2010, A1. Location in patent: Page/Page column 68-69
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 1, p. 144 - 158
[3] Patent: WO2010/123919, 2010, A2. Location in patent: Page/Page column 55
[4] Patent: WO2017/106771, 2017, A1. Location in patent: Paragraph 00397
[5] Patent: WO2017/133667, 2017, A1. Location in patent: Page/Page column 400
2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine Preparation Products And Raw materials
Raw materials2,4-Dichloro-7H-pyrrolo2,3-dpyrimidine-->p-Toluenesulfonic acid-->Tosyl chloride-->Sodium hydroxide-->Water-->Dichloromethane
Tag:2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine(934524-10-4) Related Product Information
2,4-Difluoropyrimidine 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino) piperidin-1-yl)-3-oxopropanenitrile citric acid tert-butyl methyl((3R,4R)-4-methyl-1-tosylpiperidin-3-yl)carbamate N-((3SR,4RS)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (3RS,4SR)-methyl 1-benzyl-4-methylpiperidin-3-ylcarbamate ((3R,4R)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine 4-Methyl-piperidin-3-ol 4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE (3SR,4SR)-1-benzyl-N,4-dimethylpiperidin-3-amine (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride 3-((3RS,4RS)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino) piperidin-1-yl)-3-oxopropanenitrile citric acid ((3SR,4RS-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine 2-Chloro-3,7-dihydro-4H-pyrrolo[2,3-d]pyriMidin-4-one Tofacitinib (3R,4R)-N,4-dimethyl-1-tosylpiperidin-3-amine N-((3RS,4RS)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (3RS,4SR)-1-benzyl-N-methyl-4-methylpiperidin-3-amine bis-(hydrochloride) 3-(Boc-amino)-4-picoline